Collegium Pharmaceutical (COLL) Tax Provisions (2020 - 2026)

Collegium Pharmaceutical has reported Tax Provisions for 7 years, with the latest figure at $1.5 million in Q2 2026.

• On a quarterly basis, Tax Provisions fell 69.87% year-over-year to $1.5 million in Q2 2026; TTM through Jun 2026 was $29.8 million, a 77.97% increase from a year earlier, with the FY2025 full-year figure at $29.7 million, up 1.26% from the prior year.
• Tax Provisions was $1.5 million for Q2 2026 at Collegium Pharmaceutical, down from $4.2 million in the prior quarter.
• The five-year high for Tax Provisions was $14.8 million in Q4 2023, with the low at -$2.8 million in Q1 2022.
• Average Tax Provisions over 5 years is $4.9 million, with a median of $4.8 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2024: Tax Provisions sank 1375.0% in 2022, then jumped 6900.76% in 2024.
• Over 5 years, Tax Provisions stood at -$592000.0 in 2022, then soared by 2594.93% to $14.8 million in 2023, then slumped by 67.96% to $4.7 million in 2024, then jumped by 155.08% to $12.1 million in 2025, then tumbled by 87.42% to $1.5 million in 2026.
• The last three Tax Provisions figures came in at $1.5 million (Q2 2026), $4.2 million (Q1 2026), and $12.1 million (Q4 2025), per Business Quant data.